Institutional investors purchased a net $5.1 million shares of NEO during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 27.42% of the shares outstanding that institutional investors hold is among the lowest in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.0 Million shares of Neogenomics Inc